Therapeutic implications of Benzosuberene Alkyl Sulfone BSAS analogues in the modulation of adipocyte dyshomeostasis in metabolic illness

dc.contributor.guide	Yogendra S. Padwad
dc.coverage.spatial
dc.creator.researcher	Abhishek Goel
dc.date.accessioned	2025-10-03T09:07:29Z
dc.date.available	2025-10-03T09:07:29Z
dc.date.awarded	2025
dc.date.completed	2025
dc.date.registered	2019
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	ALL
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/666144
dc.language	English
dc.publisher.institution	Biological Sciences (CSIR-IHBT)
dc.publisher.place	Ghaziabad
dc.publisher.university	Academy of Scientific and Innovative Research (AcSIR)
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Life Sciences
dc.title	Therapeutic implications of Benzosuberene Alkyl Sulfone BSAS analogues in the modulation of adipocyte dyshomeostasis in metabolic illness
dc.title.alternative	Therapeutic implications of Benzosuberene-Alkyl Sulfone (BSAS) analogues in the modulation of adipocyte dyshomeostasis in metabolic illness
dc.type.degree	Ph.D.